Anti-tumor effect of cisplatin in human oral squamous cell carcinoma was enhanced by andrographolide via upregulation of phospho-p53 in vitro and in vivo
Oral squamous cell carcinoma is one of the most common neoplasm in the world. Despite the improvements in diagnosis and treatment, the outcome is still poor now. Thus, the development of novel therapeuticapproaches is needed. The aim of this study is to assess the synergistic anti-tumor effect of an...
Saved in:
| Main Authors: | Songjie Chen, Hui Hu, Shushu Miao, Jiayong Zheng, Zhijian Xie, Hui Zhao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2017-04-01
|
| Series: | Tumor Biology |
| Online Access: | https://doi.org/10.1177/1010428317705330 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cyclo (Pro-Tyr) upregulates GmPOD53L to enhance soybean resistance to cyst nematode (Heterodera glycines Ichinohe)
by: Hui Wang, et al.
Published: (2025-07-01) -
MTMR6 downregulation contributes to cisplatin resistance in oral squamous cell carcinoma
by: Kah Young Lee, et al.
Published: (2025-01-01) -
In vitro assay identifying cisplatin resistance of head and neck squamous cell carcinoma
by: Shu-Jen Chiang, et al.
Published: (2023-09-01) -
The andrographolide derivative, AND7, and TRAIL combination attenuates acute lymphoblastic leukemia through P53-regulated ROS accumulation
by: Letian Xu, et al.
Published: (2024-04-01) -
Knockdown of RFC4 inhibits cell proliferation of oral squamous cell carcinoma in vitro and in vivo
by: Pengyue You, et al.
Published: (2025-02-01)